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Background & aims: The metabolic and functional characteristics related to sarcopenic obesity have not
been thoroughly explored in the earlier stages of the aging process. The aim of the present study was to
examine the phenotype of sarcopenic obesity, in terms of lean body mass, muscle strength and quality, in
adult women with and without the Metabolic Syndrome (MetS), and its relationship with the features of
myosteatosis.
Methods: Study participants were enrolled at the Sapienza University, Rome, Italy. Body composition was
assessed by DXA. The Handgrip strength test (HGST) was performed. HGST was normalized to arm lean
mass to indicate muscle quality; intermuscular adipose tissue (IMAT) and intramyocellular lipid content
(IMCL) were measured by magnetic resonance imaging and spectroscopy, as indicators of myosteatosis.
Different indices of sarcopenia were calculated, based on appendicular lean mass (ALM, kg) divided by
height squared, or weight. The NCEP-ATPIII criteria were used to diagnose the MetS. HOMA-IR was
calculated. The physical activity level (PAL) was assessed through the IPAQ questionnaire.
Results: 54 women (age: 48 ± 14 years, BMI: 37.9 ± 5.4 kg/m2) were included. 54% had the MetS
(metabolically unhealthy, MUO). HGST/arm lean mass was lower in MUO women than women without
the MetS (6.3 ± 1.8 vs. 7.8 ± 1.6, p ¼ 0.03). No differences emerged in terms of absolute ALM (kg) or other
indices of sarcopenia (ALM/h2 or ALM/weight) between metabolically healthy (MHO) vs. MUO women
(p > 0.05). Muscle quality was negatively associated with HOMA-IR (p ¼ 0.02), after adjustment for age,
body fat, hs-CRP levels, and PAL. IMAT, but not IMCL, was significantly higher in obese women with the
MetS compared to women without the MetS (p > 0.05). No association emerged between HGST/arm lean
mass and IMAT or IMCL when HOMA-IR was included in the models.
Conclusion: Insulin resistance, and not sarcopenia or myosteatosis per se, was associated with muscle
weakness, resulting in the phenotype of “dynapenic obesity” in middle-aged women with the metabolic
syndrome.
© 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.1. Introduction
In recent years growing interest has been directed to sarcopenic
obesity, given the parallel increase of obesity and life expectancy in
Western countries [1,2]. Alterations in body compartments are
strictly linked to energy imbalance, though multiple factors inter-
fere with energy partitioning and the consequent changes in bodytal Medicine-Medical Patho-
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s://doi.org/10.1016/j.clnu.201composition (e.g. hormone dysregulations, insulin-resistance,
inflammation, etc.) [3,4]. Even keeping weight stable, a relatively
precocious decline in lean body mass has been reported, starting
after the third decade [5,6].
Concurrently, body fat tends to redistribute from the subcu-
taneous toward the visceral depots [7]. Indeed, the presence of
obesity can precipitate and exacerbate the changes in body com-
partments. However the presence of excess fat and reduced lean
mass partially depicts the complex phenotype of sarcopenic
obesity: in fact the hallmarks of this syndrome encompass an array
of clinical aspects, mainly represented by functional impairment
and mobility limitations [8e10]. In addition, accumulatingism. All rights reserved.
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copenic obesity and metabolic alterations such as the metabolic
syndrome [11]. Insulin resistance in obese individuals may be
responsible for the development of sarcopenia through the inter-
ference with protein anabolism and protein breakdown leading to
the decrease of lean body mass [12,13]; in turn, reduced skeletal
muscle quantity favors insulin resistance, being skeletal muscle the
major target tissue of insulin action [14]. Nevertheless, muscle at-
rophy is only a partial contributor to functional features of sarco-
penia, such as weakness, namely dynapenia, and poor functionality
and performance [15e17]. Muscle quality, defined as strength
generated per unit of muscle mass, has been recognized to perform
better than absolute muscle strength in predicting global functional
capacity [18,19]. Notably, Newman et al. demonstrated that muscle
strength represents a robust predictor of mortality in older in-
dividuals, regardless of low lean mass [20]. Importantly, due to its
easiness of measurement in the clinical setting, grip strength was
validated against leg strength, with analogous and overlapping
predictive ability for mortality risk [20].
Furthermore, as shown in previous studies including elderly
participants, age-related ectopic fat infiltration within skeletal
muscle affects muscle contractility and strength generation
[21e23]. On the other hand, just few studies examined the
connection between ectopic lipid storage within myocytes (based
on muscle biopsy or magnetic resonance spectroscopy) and
strength [24,25].
The majority of studies investigating metabolic and functional
correlates of sarcopenia and sarcopenic obesity were conducted in
the geriatric population, whereas evidence is scarce regarding the
adult population.
Thus, the aims of the present study were: to investigate the
presence of the phenotypic aspects of sarcopenia, in terms of
muscle quantity: reduced skeletal muscle mass (at whole body
level and segmental level), and muscle quality: reduced muscle
strength (dynapenia), and to examine the relationship between
muscle strength, muscle quality and features of myosteatosis
(ectopic fat storage in skeletal muscle as intermuscular adipose
tissue, “IMAT”, that is adipose tissue beneath the muscle fascia and
between muscle groups, and lipid droplet deposition in myocytes
as intramyocellular lipid content “IMCL”) in metabolically healthy
(MHO) and metabolically unhealthy (MUO) adult women with
obesity.
2. Materials and methods
Study participants were recruited at the “CASCO” High
Specialization Center for the Care of Obesity, Policlinico “Umberto I”
Hospital, Sapienza University, Rome, Italy. Inclusion criteria were:
age >18 and <65 years, body mass index (BMI)  30 kg/m2,
ethnicity: Caucasian Italian subjects. As exclusion criteria, we
considered: any malignant diseases during the last 5 years, any
inflammatory or autoimmune diseases, corticosteroids for systemic
use, any medications potentially affecting body weight or body
composition, syndromic obesity, participation in a reducing-weight
program in the last three months, renal failure, heart failure, any
type of diabetes, history of viral or autoimmune liver diseases or
any other chronic liver disease, excessive alcohol intake (>70 g/
week for women), any neurodegenerative diseases, or any
musculoskeletal diseases. The study protocol was approved by the
Ethical Committee of the “Sapienza” University, Rome, Italy. Writ-
ten informed consent was obtained from all the participants. All
subjects underwent a complete physical examination. Anthropo-
metric measurements. Body weight, height, waist circumference
were measured following standardized procedures [26]. The same
tools were used in all subjects: a SECA scale 86 (200 kg, to thePlease cite this article as: Poggiogalle E et al., The decline in muscle streng
women with obesity, Clinical Nutrition, https://doi.org/10.1016/j.clnu.201nearest 0.1 kg), a flexible metallic tape (200 cm, to the nearest
0.1 cm), a telescopic stadiometer (200 cm; to the nearest 0.1 cm).
Body mass index (BMI) was calculated as body weight (kg) divided
by height squared (m2). Definition of obesity. Obesity was defined
as BMI 30 kg/m2. Body composition analysis. Fat mass (FM) and
fat-free mass (FFM) were assessed by dual-energy X-ray absorpti-
ometry (DXA) (Hologic 4500 RDR), with coefficient of varia-
tion < 1.5% for FM and FFM. Appendicular lean mass (ALM) was
evaluated by DXA and calculated as the sum of lean soft tissue
masses of arms and legs [27]. Biochemistry. Blood samples were
collected after an overnight fast. The following biochemical pa-
rameters were assayed: total cholesterol, HDL-cholesterol, LDL-
cholesterol, triglyceride, glucose and insulin, serum high-
sensitivity C-reactive protein (hs-CRP) levels, using commercial
kits. Glucose metabolism and insulin resistance. Homeostasis
model assessment of insulin resistance (HOMA-IR) was calculated
from fasting plasma insulin and glucose levels using the formula:
insulin  glucose/405 (mU/l mg/dl). Also the HOMA-b index was
calculated [insulin (mU/l)  360/glucose (mg/dl) e 63] [28]. Defi-
nition of the metabolic syndrome (MetS). MetS was diagnosed in
accordance with the criteria proposed in the National Cholesterol
Education Program- Third Adult Treatment Panel [29]. The Hand-
grip strength test (HGST) was performed according to the stan-
dardized procedure [30,31], using a digital dynamometer (DynEx,
Akern, Pontassieve, FI, Italy). For each participant, 3 measurements
on the dominant hand were averaged. Moreover, the mean value
obtained was normalized to DXA-derived arm lean mass, similar to
previous studies [32,33], and was used in the statistical analysis, as
a proxy of muscle quality [18,34]. Indices of sarcopenia and sarco-
penic obesity. Different indices of sarcopenia were calculated,
based on appendicular lean mass (ALM, kg) divided by height
squared (ALM/h2), or weight (ALM/weight), and prevalence of
sarcopenia was defined according to the afore mentioned indices,
using cutpoints calculated for the Italian population [10]. Due to the
large variability in prevalence data and the lack of a consensus on
the criterion to be used, we considered the indices of sarcopenia as
continuous variables for further analysis [35,36]. Intermuscular
adipose tissue (IMAT, please see below for methods) was divided by
thigh muscle CSA in order to obtain an index of segmental sarco-
penic obesity, modified from Tuttle et al. [37]. The physical activity
level (PAL) was assessed through the administration of the Inter-
national Physical Activity Questionnaire (IPAQ) [38].
3. Magnetic resonance (MR) imaging and spectroscopy
Data were acquired on a 3T magnet (GE Discovery 750; General
Electric Healthcare, Milwaukee, WI) with a peak gradient ampli-
tude of 50 mT/m, a time to peak of 200 msec In each examination,
subjects lay in a supine positionwith both legs placed along the axis
of the coil and immobilized by firm padding. Spectra were obtained
from the vastus lateralis of right leg, using a point-resolved spec-
troscopy sequence (PRESS) with a repetition time (TR) of 1500 and
echo time (TE) of 30 ms. A 20 mm3 voxel was positioned within the
muscle, using a T1-weighted sequence for localization, containing
as little as possible visible interstitial tissue or fat, to avoid
contamination from EMCL. The acquisition time was of approxi-
mately 24 s. Field homogeneity was automatically adjusted for each
voxel. T2 relaxation times of both metabolites were determined
from their peak amplitudes at each echo time using an exponential
least-squares fitting algorithm; saturation bands were used The
number of signal averages was 8 and the spectral collection time
was 3 ms. For the quantification of subcutaneous and visceral ad-
ipose tissue (SAT and VAT), a 3D GRE T1-weighted sequence in the
axial plane (TR, 4.2; TE, 1.3; FA, 15; matrix, 320  192; section
thickness, 5 mm, reconstructed 2.5 mm; intersection gap, 0) wasth and muscle quality in relation to metabolic derangements in adult
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Table 2
Anthropometric, metabolic characteristics, and inflammation.
MHO group MUO group p*
n ¼ 25 n ¼ 29
E. Poggiogalle et al. / Clinical Nutrition xxx (xxxx) xxx 3acquired with the IDEAL imaging and reconstruction method,
which enabled the separation between water and fat components
using the chemical shift MR technique.
MR spectra were reconstructed on a dedicated workstationwith
SAGE Dev2 0017.1 software (General Electric Healthcare, Milwau-
kee,WI). Raw datawere zero-filled once, and no filter was used. The
data were phase-corrected, Fourier-transformed, baseline-
corrected and averaged. A Marquardt curve-fitting procedure was
performed using a Lorentzian function to calculate the area under
the fat and water peaks. Spectra referenced the residual water and
IMCL-(CH2), and IMCL-(CH3) peaks at 4.7 ppm and 1.3, and 0.9 ppm
respectively. IMCL content was expressed as a percentage of the
water signal [39].
Fat-only datasets from T1-weighted LAVA sequences were
transferred to a personal computer and analyzed using a
commercially available software package (Slice-O-Matic; Tomovi-
sion Inc.; Montreal, Canada) and a procedure that has been previ-
ously described [40]. VAT and SAT were calculated at L4-L5 by
drawing a free-form ROI and manual thresholding values. Inter-
muscular adipose tissue (IMAT) was assessed as described by
Boettcher et al. [41].
4. Statistical analysis
Distributions of continuous variables were examined for skew-
ness and kurtosis, and were logarithmically transformed when
appropriate to adjust distributional patterns. Log-transformed
variables are presented as untransformed values for ease of
reading. Differences between MHO and MUO women were exam-
ined using Student's t test, and ANCOVA was used for adjustments
for the variables specified in the text and tables. Pearson c2 was
used for the comparison of the distribution of categorical variables.
Pearson's correlation was used to examine the relationship be-
tween variables. Multiple linear regression analyses were used to
examine association between muscle strength/quality and the
variables included in the models. The covariates included in the
models were chosen a priori among those factors expected to in-
fluence the dependent variable, based upon biological mechanism
or evidence from research; they are specified in the results section.
The level of significance for all statistical tests was set at p < 0.05.
Data analyses were performed using IBM SPSS Statistics, version 23
(IBM Corp., Armonk, NY).
5. Results
54 women (age: 48 ± 14 years, BMI: 37.9 ± 5.4 kg/m2) were
included. 29 out of 54 (54%) had the MetS (metabolically un-
healthy). Demographic and anthropometric characteristics are
shown in Table 1.
Prevalence of menopause and smoking habit were not signifi-
cantly different between the MHO group vs. the MUO group; noTable 1
Demographic and anthropometric characteristics of study participants.
MHO group MUO group p
n ¼ 25 n ¼ 29
Age (years) 45.4 ± 13.2 51.3 ± 13.9 0.08
BMI (kg/m2) 37.4 ± 6.2 38.4 ± 4.6 ns*
PAL^ (METs$min$week) 3821 ± 5923 2664 ± 3028 ns*
Menopause (%) 20.4 29.6 ns
Smokers (%) 14.3 28.6 ns
Legend: BMI: Body Mass Index; PAL: Physical Activity Level (International Physical
Activity Questionnaire Score); MET: Metabolic Equivalent; ^ log-transformed vari-
able; *p adjusted for age.
Please cite this article as: Poggiogalle E et al., The decline in muscle streng
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tivity level.
As displayed in Table 2, women in the MUO group exhibited (by
definition) higher diastolic blood pressure, glucose, triglyceride,
and insulin levels than their MHO counterparts, after adjustment
for age and VAT. Also HOMA-IR was significantly higher in MUO
women than MHO women (p ¼ 0.02), whereas HOMA-b was not
different between groups. No differences were observed in waist
circumference, systolic blood pressure, or hs-CRP levels.
Body composition, muscle fat infiltration and lipid storage,
and MetS. With respect to body composition, no differences were
observed between groups in terms of fat mass in absolute value,
body fat percentage, total lean body mass, and appendicular lean
mass in absolute value (Table 3).
MR-imaging revealed that VAT and IMAT were significantly
higher in the MUO group vs. MHO group p ¼ 0.002 and p ¼ 0.04,
respectively), whereas SAT, IMCL, and thigh muscle CSA were not
significantly different between groups;
Indices of sarcopenia and MetS. The prevalence of sarcopenia
in the present obese female cohort was highly variable according to
the different criteria used (no participant was identified as sarco-
penic according to the definition based on ALM/h2, whereas the
criterion for the index ALM/weight led to a prevalence rate of
52.6%). Due to that large discrepancy, we compared the different
indices as continuous variables. Indices of sarcopenia were not
significantly different between groups after adjustment for age
(ALM/h2: 9.26 ± 1.72 kg/m2 in the MHO group vs. 9.17 ± 1.19 kg/m2
in theMUO group, p¼ 0.95; ALM/weight: 0.246 ± 0.017 in theMHO
group vs. 0.239 ± 0.021 in the MUO group, p ¼ 0.22), save the
segmental index of sarcopenic obesity (IMAT normalized to thigh
muscle CSA) was higher in MUO women than MHO participants
(0.255 ± 0.334 vs. 0.152 ± 0.068, p ¼ 0.03 after adjustment for age).
Muscle strength, muscle quality, and MetS. Muscle strength
(HGST in absolute value, MUO group: 16.9 ± 4.6 vs. MHO group:
20.6 ± 4.9, p ¼ 0.008) and muscle quality (HGST normalized to arm
lean mass) were lower in MUO women than women without the
MetS (6.3 ± 1.8 vs. 7.8 ± 1.6, p ¼ 0.001, remaining significant also
after adjustment for age: p ¼ 0.03). Right arm lean mass was not
different between groups (MUO group: 2.8 ± 4.6 vs. MHO group:
2.7 ± 0.5, p ¼ 0.43) (Fig. 1).
Muscle quality and insulin resistance. Multiple linear regres-
sion analysis revealed that HGST/arm lean mass was negatively
associated to HOMA-IR (b ¼ 0.37, SE ¼ 0.16, p ¼ 0.02), after
adjustment for age, body fat, hs-CRP levels, and PAL (Fig. 2).Waist circumference (^cm) 117.5 ± 25.3 116.2 ± 11.0 nsx
Systolic BP (mmHg) 125 ± 14 133 ± 14 0.07
Diastolic BP (mmHg) 80 ± 10 86 ± 9 0.04
Triglycerides^ (mg/dl) 100 ± 30 153 ± 72 0.04
HDL- cholesterol (mg/dL) 55 ± 9 50 ± 13 ns
Glucose^ (mg/dl) 89 ± 6 107 ± 18 0.01
Insulin^ (uU/ml) 9.1 ± 4.5 14.1 ± 6.5 0.03
HOMA-IR^ 2.03 ± 1.04 3.97 ± 3.5 0.02
HOMA-b 131 ± 57 139 ± 54 ns
Hs-CRP^ (ug/l) 3544 ± 2360 6493 ± 2220 ns
Legend: MHO: metabolically healthy obese; MUO: metabolically unhealthy obese;
BP: blood pressure; HDL: high-density lipoprotein; HOMA-IR: Homeostasis Model
Assessment- Insulin Resistance; Hs-CRP: high-sensitivity C-reactive protein; ^ log-
transformed variables; *p adjusted for age and VAT(visceral adipose tissue). xp
adjusted for age.
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Table 3
Body composition and adiposity.
MHO group MUO group p*
n ¼ 25 n ¼ 29
DXA
Body fat (%) 40.2 ± 2.9 40.0 ± 4.3 ns
FM (kg) 39.1 ± 8.4 38.0 ± 8.3 ns
LBM (kg) 55.4 ± 10.0 54.0 ± 8.4 ns
ALM (kg) 23.9 ± 4.7 22.6 ± 3.5 ns
MRI
VAT^ (mm2) 9414 ± 3639 18129 ± 17,357 0.002
SAT^ (mm2) 51,173 ± 12,034 67,888 ± 99,936 ns
Thigh muscle CSA (^mm2) 10,893 ± 1690 10,747 ± 1801 ns
IMAT^ (mm2) 1614 ± 642 2655 ± 3710 0.04
MRS
IMCL^ (%) 21.5 ± 23.9 27.4 ± 26.6 ns
Legend: MHO: metabolically healthy obese; MUO: metabolically unhealthy obese;
DXA: Dual-energy X-ray absorptiometry; MRI: Magnetic resonance imaging; MRS:
Magnetic resonance spectroscopy; FM: fat mass; LBM: lean body mass; ALM:
appendicular lean mass; VAT: visceral adipose tissue; SAT: subcutaneous adipose
tissue; CSA: cross-sectional area; IMAT: intramuscular adipose tissue; IMCL: intra-
myocellular lipid content; ^ log-transformed variables; *p adjusted for age; ns: not
significant.
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Fig. 2. Association between muscle quality and insulin resistance. Legend: HGST:
handgrip strength; HOMA-IR: Homeostasis Model Assessment- Insulin Resistance; Hs-
CRP: high-sensitivity C-reactive protein; IPAQ: International Physical Activity Ques-
tionnaire; PAL: Physical Activity Level; SE: standard error.
E. Poggiogalle et al. / Clinical Nutrition xxx (xxxx) xxx4Muscle quality, muscle fat infiltration and lipid storage.
Muscle quality was inversely associated with IMAT (b ¼ 8.9*104,
SE ¼ 3.9*104, p ¼ 0.03) after adjustment for age, hs-CRP, and PAL,
but significance was lost when HOMA-IR was included in the
model. No association emerged between HGST/arm lean mass and
IMCL.
6. Discussion
A wealth of studies focused on the age-related decline of lean
body mass and muscle strength, with sarcopenia and dynapenia
being a frequent combination in the geriatric population. However
evidence is scarce in the adult population at the early stages of the
aging process.
In the present study we provide evidence that adult women
who were obese and metabolically unhealthy were weaker than
their counterparts with good metabolic health, due to reduced
muscle quality, despite no differences were detected between
groups in terms of total or appendicular muscularity. In addition,
also the indices of sarcopenia were not significantly different when
women with the metabolic syndrome were compared to0
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Fig. 1. Handgrip strength (HGST) and muscle quality in metabolically he
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women with obesity, Clinical Nutrition, https://doi.org/10.1016/j.clnu.201participants who were metabolically healthy, except for a
segmental index of sarcopenic obesity. These findings are in line
with prior studies showing that muscle strength drops at a faster
rate than muscle mass [21]. In obese subjects, probably due to an
adaptive mechanism counteracting the increased load of body fat,
approximately one quarter of the excess weight consists of fat-free
tissues [42]. Similarly, Forbes et al. reported an anabolic response in
different hormonal axes to short-term overfeeding in female vol-
unteers, leading to a substantial gain of both leanmass and fat mass
[43]. One can hypothesize that, at least in the short or intermediate
duration of obesity, the exposure to excess energy can contribute to
a relative increase of the lean compartment, and only in the long-
term the obesity-related low-grade inflammation could
contribute to the deterioration of skeletal muscle mass leading to
the phenotype of sarcopenic obesity [36,44]. Thus, in obese adults
dynapeniamay be present even in the absence of reduced LBM, and
the classical “natural history” of age-related decrease in skeletal
muscle mass and strength may follow different trajectories in
obesity.
In accordance with Kotronen et al., women with the metabolic
syndrome did not exhibit larger amount of IMCL than metabolically
healthy women, though conflicting data have been reported0
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metabolic syndrome and type 2 diabetes [45].
Interestingly, in our study population we found no association
between muscle strength/quality and fatty infiltration and lip-
otoxicity in the skeletal muscle (either IMAT or IMCL) when mul-
tiple regression analyses accounted for insulin resistance in the
models.
Longitudinal data do not seem to be conclusive regarding the
relationship between weakness and fat accumulation within skel-
etal muscle. Our observations are in agreement with findings from
a 5-year follow-up of the participants in the Health ABC study, in
whom the increase in muscle fat infiltration at the midthigh
computed tomography (CT) scan was not related to changes in
muscle strength (examined by isokinetic leg muscle torque) in both
sexes. When data analysis was performed according to weight
change, fatty infiltration of the skeletal muscle only predicted the
drop inmuscle strength inmale elders who remainedweight stable
[21]. Conversely, our results are in disagreement with prior studies
conducted in the geriatric population, demonstrating a detrimental
role of fatty infiltration on functional parameters [22]. In addition,
Visser et al. found that elders with larger mid-thigh muscle fat
infiltration evaluated by CT exhibited higher incidence of mobility
disability over a 2.5 year follow-up period [23].
Concerning the nexus between functional capacity and excess
lipid storage within muscle, only a minority of studies assessed
IMCL through magnetic resonance spectroscopy or muscle biopsy
[24,25]. Moreover, extant studies provided with conflicting find-
ings, and the effect of IMCL on muscle contractility and strength
generation remains to be further elucidated.
Based on in vitro experiments, Choi et al. demonstrated that
intramyocellular lipids were inversely related to fiber contractility
in older participants who underwent muscle biopsy of the vastus
lateralis [24]. The lack of association between muscle strength or
muscle quality and IMCL in our study population is somewhat in
agreement with findings from a Japanese study in which no sig-
nificant correlation was shown between IMCL and strength pro-
duced during isometric knee extension in older men and women
(mean age 70 years); conversely, in the same study a negative
relationship linked IMCL and strength in the young group (mean
age: 20 years) [25]. To which extent the lipid content in myocytes
interferes with muscle contractile properties, possibly influencing
internal resistance or other mechanical properties, deserves future
investigations in the normal weight as well as obese population.
Regardless of IMCL amount, IMCL composition (e.g. lipid classes
frequently associated with lipotoxicity, such as ceramides) could be
responsible for alterations underpinning muscle weakness. In fact
Ferreira and coll. clearly showed that enhanced sphingomyelinase
activity, leading to excess ceramide production, was able to activate
a pro-oxidant cascade resulting in impaired contractility and to
precocious onset of muscular fatigue [46]. Furthermore, ceramides
and other toxic lipid species, such as diacylglycerol, have been ac-
knowledges as relevant mediators in the pathogenesis of lipid-
induced insulin resistance in obesity and in type 2 diabetes [47,48].
In addition, oxidative stress related to lipotoxicity in the skele-
letal muscle is also responsible for alterations in both neurological
and muscular properties. In more detail, the accumulation of
reactive oxygen species has been identified as a major player in the
impairment of muscle fiber activation and the disruption of the
excitation-contraction coupling, resulting in loss of strength [49].
Though the hypothesis of the deleterious effects of lipid in-
termediates appears plausible, additional factors not examined in
our study could have contributed to our findings: Gaster et al.
demonstrated that the reduced expression of the glucose trans-
porter protein GLUT4 in obese and type 2 diabetic patients is
dependent on the volume of muscle fibers [50]. So we have toPlease cite this article as: Poggiogalle E et al., The decline in muscle streng
women with obesity, Clinical Nutrition, https://doi.org/10.1016/j.clnu.201acknowledge that the lack of specimens from muscle biopsies
represents the main limitation to our study, preventing the evalu-
ation of the type and the volume of muscle fibers, and lipid
composition within myocytes.
However, the point of strength of our study was indeed the
multidimensional assessment of the complex phenotype that is
sarcopenic obesity in terms of body composition, metabolic alter-
ations, and functional outcomes.7. Conclusion
Insulin resistance, and not myosteatosis or sarcopenia per se,
was associated with reduced muscle strength and quality, resulting
in the phenotype of “dynapenic obesity” in middle-aged women
with the metabolic syndrome. Greater attention should be paid to
functional consequences related to insulin resistance, as reduced
muscle strength has been associated with increased CVD risk and
mortality [51,52].Disclosure of interest
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